YNBY INTL (00030) appointed Cao Yonggang as a non-executive director.
Yun Bai International (00030) announced that Mr. Huang Bin has retired as a non-executive director at the end of the shareholders' annual meeting. As the third resolution electing Mr. Cao Yonggang as a non-executive director was formally passed at the shareholders' annual meeting, the appointment of Mr. Cao Yonggang as a non-executive director took effect at the end of the shareholders' annual meeting to fill the vacancy left by Mr. Huang Bin's retirement.
YNBY INTL (00030) announced that Mr. Huang Bin has stepped down as a non-executive director at the end of the shareholders' annual meeting. As the resolution to elect Mr. Cao Yonggang as a non-executive director has been formally passed at the shareholders' annual meeting, the appointment of Mr. Cao Yonggang as a non-executive director is effective at the end of the shareholders' annual meeting to fill the vacancy left by Mr. Huang Bin's resignation.
Related Articles
Shenzhen Hepalink Pharmaceutical Group (09989) will distribute a final dividend of 1.6604 Hong Kong dollars per 10 shares on July 22nd.
IMMUNEONCO-B(01541) redeemed 205 million Hong Kong dollars of Shenwan products and subscribed to 212 million Hong Kong dollars of Shenwan Hongyuan Group financial products.
Yueyun Trans (03399) plans to appoint KPMG Huazhen Certified Public Accountants as the new auditor.
Shenzhen Hepalink Pharmaceutical Group (09989) will distribute a final dividend of 1.6604 Hong Kong dollars per 10 shares on July 22nd.
IMMUNEONCO-B(01541) redeemed 205 million Hong Kong dollars of Shenwan products and subscribed to 212 million Hong Kong dollars of Shenwan Hongyuan Group financial products.
Yueyun Trans (03399) plans to appoint KPMG Huazhen Certified Public Accountants as the new auditor.
